Differential Factors for Predicting Outcomes in Left Main versus Non-Left Main Coronary Bifurcation Stenting
暂无分享,去创建一个
M. Jeong | S. Han | Hyo‐Soo Kim | M. Hong | K. Choi | Y. Song | H. Gwon | B. Koo | J. Doh | D. Kim | T. Ahn | B. Hwang | Kiyuk Chang | C. Nam | D. Lim | S. Rha | So-Yeon Choi | S. Hur | Junghan Yoon | I. Chae | C. Yu | H. Joo | J. Park | S. Hong | K. Cha | J. Cha | J. Heo | Jongseon Park | W. Chun | Sang Yeub Lee | J. Jeong
[1] M. Jeong,et al. Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent , 2020, Circulation. Cardiovascular interventions.
[2] J. Hartikainen,et al. Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV , 2020, Open Heart.
[3] P. Serruys,et al. Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention: Technique Analysis From the EXCEL Trial , 2018, Circulation. Cardiovascular interventions.
[4] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.
[5] G. Stone,et al. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial. , 2017, Journal of the American College of Cardiology.
[6] Yong Hwan Park,et al. Long-Term Clinical Outcomes of True and Non-True Bifurcation Lesions According to Medina Classification- Results From the COBIS (COronary BIfurcation Stent) II Registry. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[7] M. Jeong,et al. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts. , 2015, JACC. Cardiovascular interventions.
[8] M. Jeong,et al. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II. , 2014, JACC. Cardiovascular interventions.
[9] G. Stone,et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. , 2014, Journal of the American College of Cardiology.
[10] P. Smits,et al. Two‐year outcomes after deployment of XIENCE V everolimus‐eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: A report from the SPIRIT V single arm study , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[11] Lane F Burgette,et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models , 2013, Statistics in medicine.
[12] R. Ruiz-Salmerón,et al. Approach to coronary bifurcation lesions using the everolimus-eluting stent: comparison between a simple strategy and a complex strategy with T-stenting. , 2013, Revista espanola de cardiologia.
[13] R. Ruiz-Salmerón,et al. Abordaje de las lesiones bifurcadas con stent liberador de everolimus: comparación entre estrategias simple y compleja con T - stenting , 2013 .
[14] P. Serruys,et al. Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial , 2013, Heart.
[15] B. Chevalier,et al. Kissing balloon inflation in percutaneous coronary interventions. , 2012, JACC. Cardiovascular interventions.
[16] Habib Samady,et al. Contemporary clinical applications of coronary intravascular ultrasound. , 2011, JACC. Cardiovascular interventions.
[17] I. Moussa. Coronary artery bifurcation interventions: The disconnect between randomized clinical trials and patient centered decision‐making , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[18] Jun-Jie Zhang,et al. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial. , 2011, Journal of the American College of Cardiology.
[19] F. Eberli,et al. Drug-eluting versus bare-metal stents in large coronary arteries. , 2010, The New England journal of medicine.
[20] G. Stone,et al. Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial , 2009, Circulation.
[21] I. Sarembock,et al. Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[22] T. Ahn,et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes , 2006, Heart.
[23] D. Kereiakes,et al. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents. , 2005, Reviews in cardiovascular medicine.
[24] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[25] V. Chair,et al. ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi , 2011 .
[26] Writing Committee Members , 2008 .